Comparison between clinical diagnosis and CSF biomarkers of Alzheimer disease in elderly patients with late onset psychosis: Helsinki Old Age Psychosis Study (HOPS).

MLA

Seppälä, Toni T., et al. “Comparison between Clinical Diagnosis and CSF Biomarkers of Alzheimer Disease in Elderly Patients with Late Onset Psychosis: Helsinki Old Age Psychosis Study (HOPS).” The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry, vol. 22, no. 9, Sept. 2014, pp. 908–16. EBSCOhost, https://doi.org/10.1016/j.jagp.2012.08.020.

APA

Seppälä, T. T., Louhija, U.-M., Appelberg, B., Herukka, S.-K., & Juva, K. (2014). Comparison between clinical diagnosis and CSF biomarkers of Alzheimer disease in elderly patients with late onset psychosis: Helsinki Old Age Psychosis Study (HOPS). The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry, 22(9), 908–916. https://doi.org/10.1016/j.jagp.2012.08.020

Chicago

Seppälä, Toni T, Ulla-Marja Louhija, Björn Appelberg, Sanna-Kaisa Herukka, and Kati Juva. 2014. “Comparison between Clinical Diagnosis and CSF Biomarkers of Alzheimer Disease in Elderly Patients with Late Onset Psychosis: Helsinki Old Age Psychosis Study (HOPS).” The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry 22 (9): 908–16. doi:10.1016/j.jagp.2012.08.020.